?
Can Mediterranean/MIND adherence reduce progression velocity in biomarker-defined AD or PSP subgroups?
active
open question
Created: 2026-04-25T20:29:45
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-3d08dd01-ad74-4441-9194-bf
Open Question
open
Wiki: therapeutics-mediterranean-mind-diet-neurodegeneration
Can Mediterranean/MIND adherence reduce progression velocity in biomarker-defined AD or PSP subgroups?
Importance Elo
1500
Field Rank
Rank #1000 in therapeutics
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page therapeutics-mediterranean-mind-diet-neurodegeneration
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
Lifestyle Intervention Mechanisms in Alzheimer's Disease
partial answer for · experiment · 82%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:45.465009'} |
| field_tag | therapeutics |
| source_id | therapeutics-mediterranean-mind-diet-neurodegeneration |
| sub_field | mediterranean-mind-diet-neurodegeneration |
| source_kind | wiki |
| question_hash | 5cd7edc6f695d325c6dd19b53b8cf641b9334e7b5037a971ce9c962520ac9c2f |
| question_text | Can Mediterranean/MIND adherence reduce progression velocity in biomarker-defined AD or PSP subgroups? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page therapeutics-mediterranean-mind-diet-neurodegeneration |
| evidence_xref_at | 2026-04-27T12:09:11.252607+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
2
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.